79114443 - LNA-ANTIMIR

Information

• Trademark
• 79114443

• Source

• Serial Number

  79114443

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 04, 2012
  12 years ago

• Transaction Date

  August 01, 2022
  2 years ago

• Status Date

  January 04, 2022
  2 years ago

• Location Date

  February 22, 2013
  11 years ago

• Status Code

  402

• Current Location

  TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  LAVACHE, LINDA M

• Law Office Assigned Location Code

  L60

• Owners

  • Santaris Pharma A/S

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseases
• PM0000: LNA-ANTIMI R
• GS0011: Chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and development
• GS0421: Scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and products

Case File Event Statements

• 8/1/2022 - 2 years ago

  21 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENA

• 7/31/2022 - 2 years ago

  20 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 11/7/2014 - 10 years ago

  19 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 3/13/2014 - 10 years ago

  18 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT

• 2/24/2014 - 10 years ago

  17 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 2/22/2014 - 10 years ago

  16 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 1/11/2014 - 10 years ago

  15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 12/26/2013 - 10 years ago

  14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/25/2013 - 10 years ago

  13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 2/22/2013 - 11 years ago

  12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 2/22/2013 - 11 years ago

  11 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 8/17/2012 - 12 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/27/2012 - 12 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 7/27/2012 - 12 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 7/27/2012 - 12 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 7/27/2012 - 12 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 7/26/2012 - 12 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/23/2012 - 12 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/23/2012 - 12 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/20/2012 - 12 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 7/19/2012 - 12 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR